LB1017 prevents insurance companies from establishing specialty tiers to cover biologics, plasma-derived therapies and their recombinants, and other expensive therapies.
Feb 16 201006:05AM CT
KFOR-NBC
Oklahoma City, OK
LB 1017 Introduced Play and download file
Feb 16 201006:00PM CT
KOLN-CBS
Lincoln-Hastings-Kearney, NE
LB 1017 Introduced Play and download file